G. Charles Robb
2017
In 2017, G. Charles Robb earned a total compensation of $1.8M as Chief Financial Officer and Secretary at Corcept Therapeutics, a 98% increase compared to previous year.
Compensation breakdown
| Bonus | $320,000 |
|---|---|
| Option Awards | $1,062,589 |
| Salary | $397,929 |
| Total | $1,780,518 |
Robb received $1.1M in option awards, accounting for 60% of the total pay in 2017.
Robb also received $320K in bonus and $397.9K in salary.
Rankings
In 2017, G. Charles Robb's compensation ranked 6,082nd out of 14,666 executives tracked by ExecPay. In other words, Robb earned more than 58.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,082 out of 14,666 | 59th |
Division Manufacturing | 2,235 out of 5,772 | 61st |
Major group Chemicals And Allied Products | 705 out of 2,075 | 66th |
Industry group Drugs | 543 out of 1,731 | 69th |
Industry Pharmaceutical Preparations | 427 out of 1,333 | 68th |
Source: SEC filing on April 24, 2018.
Robb's colleagues
We found four more compensation records of executives who worked with G. Charles Robb at Corcept Therapeutics in 2017.